Case Study: How Bausch + Lomb Doubled Persistence and Accelerated Rx Growth through Behavioral Personalization Models
Wed, Sep 16
|
11:15 AM - 11:40 AM
Terrace Ballroom IV
Session details:
Every brand has patient journeys, but over 60% of chronic patients drop off medication within the first 6 months. Adherence and persistence still universally remain major challenges to growth and health outcomes. In this session, Xiidra (2025 Fierce Pharma Marketer of the Year) will walk through the innovative framework they built to successfully personalize omnichannel messaging to drive real improvement in adherence, persistence, health outcomes, growth and value.
- Learn how the Xiidra Insider program used behavioral science, predictive modeling, and omnichannel engagement to contribute to a 30%+ increase in prescriptions by more than doubling treatment persistence
- Learn how Bausch + Lomb redesigned the Xiidra patient experience by identifying behavioral signals that predict prescription abandonment and treatment discontinuation
- Understand how behavioral intelligence can personalize support beyond demographics and clinical characteristics to address individual adherence barriers, while satisfying regulatory requirements
- Explore a scalable framework that commercial teams can apply across specialty brands to improve patient outcomes while increasing marketing efficacy
- You will walk away with inspiration and actionable growth strategies to apply deep personalization for your brand and portfolio which affect